MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors

Modern Pathology

Volumn 28, Issue 6, 2015, Pages 748-757

  Mancikova, Veronika ^a   Castelblanco, Esmeralda ^b   Pineiro Yanez, Elena ^a   Perales Paton, Javier ^a   De Cubas, Aguirre A ^a   Inglada Perez, Lucia ^a,c   Matias Guiu, Xavier ^b   Capel, Ismael ^d   Bella, Maria ^d   Lerma, Enrique ^e   Riesco Eizaguirre, Garcilaso ^f,g   Santisteban, Pilar ^f   Maravall, Francisco ^b   Mauricio, Didac ^h,i   Al Shahrour, Fatima ^a   Robledo, Mercedes ^a,c  

^a Structural Biology and Biocomputing Programme   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d HOSPITAL DE SABADELL   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^g HOSPITAL DE MÓSTOLES   (Spain)

^h FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

ⁱ HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; FIBROBLAST GROWTH FACTOR RECEPTOR 4; MICRORNA; MICRORNA 1179; MICRORNA 1247; MICRORNA 146B; MICRORNA 182; MICRORNA 183; MICRORNA 204; MICRORNA 221; MICRORNA 222; MICRORNA 34A; MICRORNA 451A; MICRORNA 486; MICRORNA 515; MICRORNA 7; MICRORNA 96; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DNA METHYLATION; DOWN REGULATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NEXT GENERATION SEQUENCING; PREDICTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; UPREGULATION; ADENOCARCINOMA; ADOLESCENT; CARCINOMA; CLUSTER ANALYSIS; DISEASE FREE SURVIVAL; GENETICS; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; THYROID TUMOR; YOUNG ADULT;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA; CLUSTER ANALYSIS; DISEASE-FREE SURVIVAL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; THYROID NEOPLASMS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84930178912     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2015.44     Document Type: Article

References (42)

1. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866
2. Calin GA, Ferracin M, Cimmino A et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353: 1793-1801
3. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005;435: 834-838
4. Rossing M. Classification of follicular cell-derived thyroid cancer by global RNA profiling. J Mol Endocrinol 2013;50:R39-R51
5. Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 2011;7: 569-580
6. Kebebew E, Greenspan FS, Clark OH et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005;103:1330-1335
7. DeLellis R, Lloyd R, Heitz P et al. Pathology and genetics of tumours of endocrine organs. IARC Press: Lyon. 2004
8. Giordano TJ, Kuick R, Thomas DG et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 2005;24:6646-6656
9. Mancikova V, Buj R, Castelblanco E et al. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival. Int J Cancer 2014;135:598-610
10. Montero-Conde C, Martin-Campos JM, Lerma E et al. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information. Oncogene 2008;27:1554-1561
11. Pallante P, Battista S, Pierantoni GM et al. Deregulation of microRNA expression in thyroid neoplasias. Nat Rev Endocrinol 2014;10:88-101
12. He H, Jazdzewski K, Li W et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 2005;102:19075-19080
13. Jazdzewski K, Murray EL, Franssila K et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008;105:7269-7274
14. Nikiforova MN, Tseng GC, Steward D et al. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 2008;93:1600-1608
15. Pallante P, Visone R, Ferracin M et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 2006;13:497-508
16. Swierniak M, Wojcicka A, Czetwertynska M et al. Indepth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma. J Clin Endocrinol Metab 2013;98:E1401-E1409
17. Tetzlaff MT, Liu A, Xu X et al. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 2007;18:163-173
18. Cancer Genome Atlas Research Network Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014;159:676-690
19. Huang CT, Oyang YJ, Huang HC et al. MicroRNAmediated networks underlie immune response regulation in papillary thyroid carcinoma. Sci Rep 2014;4:6495
20. Andrews S. FastQC a quality-control tool for highthroughput sequence data http://www.bioinformatics.- babraham.ac.uk/projects/fastqc
21. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 2011;17: 10-12
22. Langmead B, Trapnell C, Pop M et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009;10:R25
23. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139-140
24. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300
25. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw 2010;33:1-22
26. Morozova O, Marra MA. Applications of nextgeneration sequencing technologies in functional genomics. Genomics 2008;92:255-264
27. Visone R, Russo L, Pallante P et al. MicroRNAs (miR)- 221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 2007;14: 791-798
28. Cahill S, Smyth P, Finn SP et al. Effect of ret/PTC 1 rearrangement on transcription and posttranscriptional regulation in a papillary thyroid carcinoma model. Mol Cancer 2006;5:70
29. Ma Y, Qin H, Cui Y. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Biochem Biophys Res Commun 2013;441:958-963
30. Arora N, Scognamiglio T, Zhu B et al. Do benign thyroid nodules have malignant potential?. An evidencebased review. World J Surg 2008;32:1237-1246
31. Dettmer M, Vogetseder A, Durso MB et al. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. J Clin Endocrinol Metab 2013;98:E1-E7
32. Rossing M, Borup R, Henao R et al. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. J Mol Endocrinol 2012;48: 11-23
33. Kim YK, Yeo J, Kim B et al. Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell 2012;46: 893-895
34. Shi S, Lu Y, Qin Y et al. miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins. Curr Mol Med 2014;14:316-327
35. Dettmer MS, Perren A, Moch H et al. MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights. J Mol Endocrinol 2014;52:181-189
36. Wang FE, Zhang C, Maminishkis A et al. MicroRNA- -204/211 alters epithelial physiology. FASEB J 2010;24: 1552-1571
37. Xing M, Westra WH, Tufano RP et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005;90: 6373-6379
38. Johnson SM, Grosshans H, Shingara J et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120: 635-647
39. Yu S, Liu Y, Wang J et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 2012;97:2084-2092
40. Feng S, Cong S, Zhang X et al. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 2011;39:6669-6678
41. Kim T, Veronese A, Pichiorri F et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011;208: 875-883
42. Song B, Wang Y, Kudo K et al. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 2008;14:8080-8086